Copyright © 2012 Joshua Z. Press and Walter H. Gotlieb. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. W. J. Koh, “Early stage endometrial cancer: to radiate or not to radiate-that is the question,” Gynecologic Oncology, vol. 110, no. 3, pp. 271–274, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
2. D. Querleu, E. Leblanc, and B. Castelain, “Laparoscopic pelvic lymphadenectomy in the staging of early carcinoma of the cervix,” American Journal of Obstetrics & Gynecology, vol. 164, pp. 579–581, 1991.
3. J. L. Walker, M. R. Piedmonte, N. M. Spirtos et al., “Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: gynecologic Oncology Group Study LAP2,” Journal of Clinical Oncology, vol. 27, no. 32, pp. 5331–5336, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
4. A. B. Kornblith, H. Q. Huang, J. L. Walker, N. M. Spirtos, J. Rotmensch, and D. Cella, “Quality of life of patients with endometrial cancer undergoing laparoscopic International Federation of gynecology and obstetrics staging compared with laparotomy: a Gynecologic Oncology Group study,” Journal of Clinical Oncology, vol. 27, no. 32, pp. 5337–5342, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
5. M. Janda, V. Gebski, A. Brand et al., “Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial,” The Lancet Oncology, vol. 11, no. 8, pp. 772–780, 2010. View at Publisher · View at Google Scholar · View at Scopus
6. M. J. E. Mourits, C. B. Bijen, H. J. Arts et al., “Safety of laparoscopy versus laparotomy in early-stage endometrial cancer: a randomised trial,” The Lancet Oncology, vol. 11, no. 8, pp. 763–771, 2010. View at Publisher · View at Google Scholar · View at Scopus
7. C. Diaz-Arrastia, C. Jurnalov, G. Gomez, and C. Townsend, “Laparoscopic hysterectomy using a computer-enhanced surgical robot,” Surgical Endoscopy and Other Interventional Techniques, vol. 16, no. 9, pp. 1271–1273, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
8. P. J. Paley, D. S. Veljovich, and C. A. Shah, “Surgical outcomes in gynecologic oncolgy in the era of robotics: analysis of first 1000 cases,” American Journal of Obstetrics & Gynecology, vol. 204, pp. 551.e1–551.e9, 2011.
9. Z. Vaknin, T. Perri, S. Lau et al., “Outcome and quality of life in a prospective cohort of the first 100 robotic surgeries for endometrial cancer, with focus on elderly patients,” International Journal of Gynecological Cancer, vol. 20, no. 8, pp. 1367–1373, 2010.
10. F. Peeters, Z. Vaknin, S. Lau, C. Deland, S. Brin, and W. H. Gotlieb, “Technical modifications in the robotic-assisted surgical approach for gynaecologic operations,” Journal of Robotic Surgery, vol. 4, no. 4, pp. 253–257, 2010. View at Publisher · View at Google Scholar · View at Scopus
11. M. C. Bell, J. Torgerson, U. Seshadri-Kreaden, A. W. Suttle, and S. Hunt, “Comparison of outcomes and cost for endometrial cancer staging via traditional laparotomy, standard laparoscopy and robotic techniques,” Gynecologic Oncology, vol. 111, no. 3, pp. 407–411, 2008. View at Publisher · View at Google Scholar · View at PubMed
12. J. C. Barnett, J. P. Judd, J. M. Wu, C. D. Scales, E. R. Myers, and L. J. Havrilesky, “Cost comparison among robotic, laparoscopic, and open hysterecomy for endometrial cancer,” Obstetrics & Gynecology, vol. 116, pp. 685–693, 2010.
13. Z. Vaknin, S. Lau, V. R. Agnihotram et al., “Outcomes and cost following the introduction of a robotics program for endometrial cancer surgery,” Obstetrices and Gynecology, vol. 119, no. 4, pp. 1–10, 2012.
14. W. T. Creasman, C. P. Morrow, B. N. Bundy, H. D. Homesley, J. E. Graham, and P. B. Heller, “Surgical pathologic spread patterns of endometrial cancer. A gynecologic oncology group study,” Cancer, vol. 60, no. 8, pp. 2035–2041, 1987. View at Scopus
15. C. P. Morrow, B. N. Bundy, R. J. Kurman et al., “Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study,” Gynecologic Oncology, vol. 40, no. 1, pp. 55–65, 1991. View at Publisher · View at Google Scholar · View at Scopus
16. W. T. Creasman, D. E. Mutch, and T. J. Herzog, “ASTEC lymphadenectomy and radiation therapy studies: are conclusions valid?” Gynecologic Oncology, vol. 116, no. 3, pp. 293–294, 2010. View at Publisher · View at Google Scholar · View at PubMed
17. L. G. Seamon, J. M. Fowler, and D. E. Cohn, “Lymphadenectomy for endometrial cancer: the controversy,” Gynecologic Oncology, vol. 117, no. 1, pp. 6–8, 2010. View at Publisher · View at Google Scholar · View at PubMed
18. P. B. Panici, S. Basile, F. Maneschi et al., “Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial,” Journal of the National Cancer Institute, vol. 100, no. 23, pp. 1707–1716, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
19. ASTEC Study Group, “Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomized study,” The Lancet, vol. 373, no. 9658, pp. 125–136, 2009.
20. ASTEC Study Group, “Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review and meta-analysis,” The Lancet, vol. 373, no. 9658, pp. 137–146, 2009.
21. A. A. Mendivil, M. A. Rettenmaier, C. Cox et al., “Acute and delayed complications from surgery and adjuvant radiotherapy in the treatment of high-risk endometrial cancer,” Oncology, vol. 81, no. 2, pp. 79–83, 2011. View at Publisher · View at Google Scholar · View at PubMed
22. I. Ben-Shachar, J. Pavelka, D. E. Cohn et al., “Surgical staging for patients presenting with grade 1 endometrial carcinoma,” Obstetrics and Gynecology, vol. 105, no. 3, pp. 487–493, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
23. B. A. Goff and L. W. Rice, “Assessment of depth of myometrial invasion in endometrial adenocarcinoma,” Gynecologic Oncology, vol. 38, no. 1, pp. 46–48, 1990. View at Publisher · View at Google Scholar · View at Scopus
24. A. Mariani, S. C. Dowdy, W. A. Cliby et al., “Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging,” Gynecologic Oncology, vol. 109, no. 1, pp. 11–18, 2008. View at Publisher · View at Google Scholar · View at PubMed
25. F. Khoury-Collado, G. E. Glaser, O. Zivanovic et al., “Improving sentinel lymph node detection rates in endometrial cancer: how many cases are needed?” Gynecologic Oncology, vol. 115, no. 3, pp. 453–455, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
26. N. R. Abu-Rustum, F. Khoury-Collado, N. Pandit-Taskar et al., “Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma?” Gynecologic Oncology, vol. 113, no. 2, pp. 163–169, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
27. M. Ballester, G. Dubernard, F. Lécuru et al., “Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO),” The Lancet Oncology, vol. 12, no. 5, pp. 469–476, 2011. View at Publisher · View at Google Scholar
28. S. Kang, H. J. Yoo, J. H. Hwang, M.-C. Lim, S.-S. Seo, and S.-Y. Park, “Sentinel lymph node biopsy in endometrial cancer: meta-analysis of 26 studies,” Gynecologic Oncology, vol. 123, no. 3, pp. 522–527, 2011. View at Publisher · View at Google Scholar · View at PubMed
29. C. L. Creutzberg, W. L. J. Van Putten, P. C. M. Koper et al., “Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial,” The Lancet, vol. 355, no. 9213, pp. 1404–1411, 2000. View at Scopus
30. A. N. Scholten, W. L. J. Van Putten, H. Beerman et al., “Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review,” International Journal of Radiation Oncology Biology Physics, vol. 63, no. 3, pp. 834–838, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
31. H. M. Keys, J. A. Roberts, V. L. Brunetto et al., “A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study,” Gynecologic Oncology, vol. 92, no. 3, pp. 744–751, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
32. R. A. Nout, V. T. H. B. M. Smit, H. Putter et al., “Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial,” The Lancet, vol. 375, no. 9717, pp. 816–823, 2010. View at Publisher · View at Google Scholar · View at Scopus
33. R. A. Nout, H. Putter, I. M. Jürgenliemk-Schulz et al., “Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial,” Journal of Clinical Oncology, vol. 27, no. 21, pp. 3547–3556, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
34. M. E. Randall, V. L. Filiaci, H. Muss et al., “Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a gynecologic oncology group study,” Journal of Clinical Oncology, vol. 24, no. 1, pp. 36–44, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
35. G. F. Fleming, V. L. Brunetto, D. Cella et al., “Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a gynecologic oncology group study,” Journal of Clinical Oncology, vol. 22, no. 11, pp. 2159–2166, 2004. View at Publisher · View at Google Scholar · View at PubMed
36. K. Greven, K. Winter, K. Underhill, J. Fontenesci, J. Cooper, and T. Burke, “Final analysis of RTOG 9708: Adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer,” Gynecologic Oncology, vol. 103, no. 1, pp. 155–159, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus